We're pleased to introduce LATISSE™
(bimatoprost ophthalmic solution) 0.03%-
the first and only FDA - approved prescription
treatment for hypotrichosis used to grow
eyelashes, making them longer, thicker, and darker.
Eyelash hypotrichosis is another name for having
inadequate or not enough eyelashes.
Important Safety Information
Do not use LATISSE™ solution if you are allergic to one of its ingredients.
LATISSE™ solution is intended for use on the skin of the upper eyelid margins at
the base of the eyelashes. DO NOT APPLY to the lower eyelid. If you have a history
of abnormal intraocular pressure (IOP), you should only use LATISSE™ under the
close supervision of your physician.
LATISSE™ use may cause darkening of the eyelid skin which may be reversible.
Although not reported in clinical studies, LATISSE™ use may also cause increased
brown pigmentation of the colored part of the eye which is likely to be permanent.
You should tell your physician you are using LATISSE™ especially if you have a history
of eye pressure problems. You should also tell anyone conducting an eye pressure
screening that you are using LATISSE™ .
The most common side effects after using LATISSE™ solution are an itching sensation
in the eyes and/or eye redness. This was reported in approximately 4% of patients.
LATISSE™ solution may cause other less common side effects which typically occur
on the skin close to where LATISSE™ is applied, or in the eyes. These include skin
darkening, eye irritation, dryness of the eyes, and redness of the eyelids.
Click here for full prescribing information.
|
Unretouched photos of LATISSE™ users in the clinical trial before starting treatment and at week 16.
The onset of effect with LATISSE™ solution is gradual. In the clinical trial, the majority of users
saw significant improvement by 2 months. - Individual results may vary.
Come in today for the newest innovation in lashes.
Ask if LATISSE™ is right for you.
|
